BOOK
Hybrid PET/MR Imaging, An Issue of Magnetic Resonance Imaging Clinics of North America, E-Book
Weili Lin | Sheng-Che Hung | Yueh Z. Lee | Terence Z. Wong
(2017)
Additional Information
Book Details
Abstract
This issue of MRI Clinics of North America focuses on Imaging of the PET/MR Imaging, and articles will include: Principles of PET/MR Imaging; Attenuation Correction of PET/MR Imaging; MR-Derived Improvements in PET Imaging; Neurological Applications of PET/MR; Oncological Applications of PET/MR Imaging on the Head and Neck; Oncological Applications of PET/MR Imaging on GYN/GU; PET/MR Imaging of Multiple Myeloma; Pediatric Nuances of PET/MR Imaging; Cardiac Applications of PET/MR Imaging; Logistics and Practical Considerations of MR Coils for PET/MR; Integration of PET/MR Hybrid Imaging into Radiation Therapy Treatment; Practical Clinical Considerations of PET/MR; Incremental value of FDG PET/MR in Assessment of Rectal Cancer, and more!
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Hybrid PET/MR Imaging\r | i | ||
| Copyright\r | ii | ||
| Contributors | iii | ||
| CONSULTING EDITORS | iii | ||
| EDITORS | iii | ||
| AUTHORS | iii | ||
| Contents | vii | ||
| Foreword | vii | ||
| Preface: Hybrid PET/MR: State-of-the-Art and Future Challenges\r | vii | ||
| Principles of Simultaneous PET/MR Imaging\r | vii | ||
| Attenuation Correction of PET/MR Imaging | vii | ||
| Magnetic Resonance–Derived Improvements in PET Imaging | vii | ||
| Improved Detection of Small Pulmonary Nodules Through Simultaneous MR/PET Imaging | vii | ||
| Practical Considerations for Clinical PET/MR Imaging | viii | ||
| Neurologic Applications of PET/MR Imaging | viii | ||
| PET–MR Imaging in Head and Neck | viii | ||
| Cardiac Applications of PET/MR Imaging | viii | ||
| Applications of PET/MR Imaging in Urogynecologic and Genitourinary Cancers | ix | ||
| PET/MR Imaging of Multiple Myeloma | ix | ||
| Pediatric Applications of Hybrid PET/MR Imaging | ix | ||
| Integration of PET/MR Hybrid Imaging into Radiation Therapy Treatment | ix | ||
| MAGNETIC RESONANCE IMAGING\rCLINICS OF NORTH AMERICA\r | x | ||
| FORTHCOMING ISSUES | x | ||
| August 2017 | x | ||
| November 2017 | x | ||
| February 2018 | x | ||
| RECENT ISSUES | x | ||
| February 2017 | x | ||
| November 2016 | x | ||
| August 2016 | x | ||
| CME Accreditation Page | xi | ||
| PROGRAM OBJECTIVE | xi | ||
| TARGET AUDIENCE | xi | ||
| LEARNING OBJECTIVES | xi | ||
| ACCREDITATION | xi | ||
| DISCLOSURE OF CONFLICTS OF INTEREST | xi | ||
| UNAPPROVED/OFF-LABEL USE DISCLOSURE | xi | ||
| TO ENROLL | xii | ||
| METHOD OF PARTICIPATION | xii | ||
| CME INQUIRIES/SPECIAL NEEDS | xii | ||
| Foreword | xiii | ||
| Preface\r | xv | ||
| Hybrid PET/MR: State-of-the-Art and Future Challenges\r | xv | ||
| REFERENCES | xvi | ||
| Principles of Simultaneous PET/MR Imaging | 231 | ||
| Key points | 231 | ||
| INTRODUCTION | 231 | ||
| TECHNICAL ASPECTS THAT MUST BE CONSIDERED FOR INTEGRATING PET AND MR IMAGING | 232 | ||
| Considerations on the PET Side | 232 | ||
| Considerations on the Magnetic Resonance Side | 232 | ||
| INTEGRATED PET/MR IMAGING HARDWARE FOR WHOLE-BODY HUMAN IMAGING | 233 | ||
| Siemens Biograph mMR | 233 | ||
| General Electric SIGNA PET/MR Imaging | 233 | ||
| MAGNETIC RESONANCE-BASED PET ATTENUATION CORRECTION | 234 | ||
| Standard Protocols Approved for Clinical Use | 234 | ||
| Special Considerations | 234 | ||
| Bone imaging | 234 | ||
| Truncation artifacts | 234 | ||
| Metallic implants | 235 | ||
| Lung imaging | 235 | ||
| Magnetic resonance hardware | 235 | ||
| The Potential Added Value of the Time-of-Flight Information | 235 | ||
| PROMISING RESEARCH AND CLINICAL APPLICATIONS | 237 | ||
| Opportunities for Methodologic Cross-Validation and Improvement | 237 | ||
| Opportunities for Synergistic Use of the Multimodal Information | 238 | ||
| Neurology/psychiatry/neuroscience | 238 | ||
| Oncology | 238 | ||
| Cardiology | 239 | ||
| REFERENCES | 239 | ||
| Attenuation Correction of PET/MR Imaging | 245 | ||
| Key points | 245 | ||
| INTRODUCTION | 245 | ||
| ATLAS-BASED APPROACHES | 246 | ||
| Image Registration | 247 | ||
| Voxel-Based Pseudo-Computed Tomography Generation | 247 | ||
| Patch-Based Pseudo-Computed Tomography Generation | 247 | ||
| Machine Learning–Based Pseudo-Computed Tomography Generation | 248 | ||
| Summary | 249 | ||
| DIRECT IMAGING METHODS | 250 | ||
| Direct Imaging with Segmentation Only | 250 | ||
| Direct Imaging Methods with Segmentation and Continuous Linear Attenuation Coefficient Value Conversion | 251 | ||
| Summary | 252 | ||
| SUMMARY | 253 | ||
| REFERENCES | 253 | ||
| Magnetic Resonance–Derived Improvements in PET Imaging | 257 | ||
| Key points | 257 | ||
| INTRODUCTION | 257 | ||
| MAGNETIC RESONANCE–BASED MOTION CORRECTION OF PET IMAGES | 258 | ||
| Cyclic Motion: Respiratory | 259 | ||
| Cyclic Motion: Cardiac | 261 | ||
| Noncyclic Head Motion | 262 | ||
| Noncyclic Gross Body Motion | 263 | ||
| Clinical Impacts of Motion Correction | 263 | ||
| MAGNETIC RESONANCE-GUIDED RESOLUTION IMPROVEMENT OF PET IMAGES | 264 | ||
| Region-Based Partial Volume Correction Methods | 264 | ||
| Postreconstruction MR-Guided Image Corrections | 265 | ||
| MR-Guided PET Reconstruction Methods | 267 | ||
| Evaluation and Clinical Impacts | 269 | ||
| SUMMARY | 269 | ||
| REFERENCES | 270 | ||
| Improved Detection of Small Pulmonary Nodules Through Simultaneous MR/PET Imaging | 273 | ||
| Key points | 273 | ||
| INTRODUCTION | 273 | ||
| LUNG MOTION CORRECTION IN MAGNETIC RESONANCE/PET: PREVIOUS LIMITATIONS | 274 | ||
| Retrospective Motion Correction for Magnetic Resonance/PET Data | 274 | ||
| Prospective Motion Correction for Magnetic Resonance/PET Data | 274 | ||
| METHODS | 275 | ||
| RESULTS | 276 | ||
| DISCUSSION | 277 | ||
| REFERENCES | 277 | ||
| Practical Considerations for Clinical PET/MR Imaging | 281 | ||
| Key points | 281 | ||
| WORKFLOW, PROTOCOLLING, REPORTING AND BILLING | 281 | ||
| MR IMAGING AND RADIATION SAFETY | 283 | ||
| WHOLE-BODY PET/MR IMAGING ACQUISITION | 284 | ||
| Comparison of Whole-Body PET/MR Imaging and PET/Computed Tomography Protocols | 284 | ||
| Sequences | 287 | ||
| Tailoring PET/MR Imaging to the Clinical Application | 287 | ||
| DEDICATED REGIONAL MR IMAGING | 290 | ||
| PET PROTOCOL | 290 | ||
| ARTIFACTS AND PITFALLS | 292 | ||
| SUMMARY | 294 | ||
| REFERENCES | 294 | ||
| Neurologic Applications of PET/MR Imaging | 297 | ||
| Key points | 297 | ||
| INTRODUCTION | 297 | ||
| PET/MR IMAGING PROTOCOLS | 298 | ||
| PET/MR IMAGING BENEFITS AND CHALLENGES | 299 | ||
| APPLICATIONS | 300 | ||
| Oncology | 300 | ||
| Tumor grading and differential diagnosis | 301 | ||
| Tumor extension and treatment planning | 302 | ||
| Treatment follow-up | 303 | ||
| Evaluation of metastatic disease | 303 | ||
| Role of PET/MR imaging in neurooncology | 303 | ||
| Epilepsy | 304 | ||
| Dementia | 305 | ||
| Structural MR imaging | 306 | ||
| Perfusion-weighted imaging | 306 | ||
| Amyloid PET | 306 | ||
| Tau PET | 306 | ||
| 18F-FDG PET | 307 | ||
| PET/MR imaging in dementia research | 307 | ||
| CEREBROVASCULAR DISEASE | 307 | ||
| Cerebral Perfusion | 307 | ||
| Carotid Plaque Imaging | 307 | ||
| NEUROLOGIC AND PSYCHIATRIC DISORDERS | 307 | ||
| SUMMARY | 308 | ||
| REFERENCES | 308 | ||
| PET–MR Imaging in Head and Neck | 315 | ||
| Key points | 315 | ||
| INTRODUCTION | 315 | ||
| T-STAGING | 316 | ||
| N-STAGING | 317 | ||
| M-STAGING | 318 | ||
| STANDARDIZED UPTAKE VALUE QUANTITATION | 320 | ||
| ADVANCED MR IMAGING TECHNIQUES | 320 | ||
| DIFFUSION-WEIGHTED IMAGING | 320 | ||
| PERFUSION IMAGING | 320 | ||
| THERAPY RESPONSE ASSESSMENT | 321 | ||
| TREATMENT AND RADIOTHERAPY PLANNING | 321 | ||
| APPLICATION OF NOVEL TRACERS | 321 | ||
| SUMMARY | 322 | ||
| ACKNOWLEDGMENTS | 322 | ||
| REFERENCES | 322 | ||
| Cardiac Applications of PET/MR Imaging | 325 | ||
| Key points | 325 | ||
| INTRODUCTION | 325 | ||
| TECHNICAL CHALLENGES OF PET/MR CARDIOVASCULAR IMAGING | 326 | ||
| Attenuation Correction | 326 | ||
| Motion Correction | 327 | ||
| Optimizing Myocardial PET Signal Uptake | 328 | ||
| PET/MR IN CLINICAL CARDIAC IMAGING | 328 | ||
| PET/Magnetic Resonance Assessment of Myocardial Viability and Infarction | 328 | ||
| PET/Magnetic Resonance in Detecting Myocardial Ischemia | 328 | ||
| PET/Magnetic Resonance in Detecting Atherosclerosis | 329 | ||
| PET/Magnetic Resonance in Other Cardiac Conditions | 330 | ||
| PET/magnetic resonance in cardiac mass assessments | 330 | ||
| Conditions associated with myocardial fibrosis and inflammation | 330 | ||
| PERFORMING A SIMULTANEOUS PET/MAGNETIC RESONANCE CLINICAL EXAMINATION: THE IMAGING PROTOCOL | 330 | ||
| SUMMARY | 331 | ||
| REFERENCES | 331 | ||
| Applications of PET/MR Imaging in Urogynecologic and Genitourinary Cancers | 335 | ||
| Key points | 335 | ||
| APPLICATIONS OF PET/MR IMAGING IN GYNECOLOGIC CANCERS | 335 | ||
| Introduction | 335 | ||
| What Is PET/Magnetic Resonance? | 335 | ||
| What Is the Evidence for, and Ongoing Work on, PET/Magnetic Resonance? | 336 | ||
| How Is PET/Magnetic Resonance Done? Protocolling PET/Magnetic Resonance and Other Issues | 337 | ||
| When Is PET/Magnetic Resonance Used? Current Guidelines and Applications | 338 | ||
| Cervical (and vulvar) cancer | 339 | ||
| Endometrial cancer | 339 | ||
| Ovarian cancer | 342 | ||
| Quantitative Imaging | 344 | ||
| PET/MAGNETIC RESONANCE OF OTHER GENITOURINARY STRUCTURES | 344 | ||
| PET/Magnetic Resonance of the Prostate | 344 | ||
| PET/Magnetic Resonance of the Kidneys and Bladder | 345 | ||
| PET/Magnetic Resonance of the Scrotum and Penis | 346 | ||
| SUMMARY | 346 | ||
| REFERENCES | 347 | ||
| PET/MR Imaging of Multiple Myeloma | 351 | ||
| Key points | 351 | ||
| INTRODUCTION | 351 | ||
| IMAGING WITH FLUORODEOXYGLUCOSE PET AND MAGNETIC RESONANCE: CURRENT RECOMMENDATIONS | 352 | ||
| APPLICATIONS OF PET AND MAGNETIC RESONANCE IMAGING IN PLASMA CELL DYSCRASIAS | 353 | ||
| Staging | 355 | ||
| Prognosis | 355 | ||
| Response to Therapy | 357 | ||
| INTRODUCING PET/MAGNETIC RESONANCE | 357 | ||
| USES OF PET/MAGNETIC RESONANCE IN THE CLINICAL ARENA | 359 | ||
| PERFORMING THE EXAMINATION: BILLING AND WORKFLOW | 360 | ||
| PERFORMING THE EXAMINATION: SCAN PROTOCOL | 360 | ||
| WHEN ARE PET/MAGNETIC RESONANCE USED? | 362 | ||
| SUMMARY | 362 | ||
| REFERENCES | 362 | ||
| Pediatric Applications of Hybrid PET/MR Imaging | 367 | ||
| Key points | 367 | ||
| RADIATION DOSE REDUCTION | 367 | ||
| PET/MR IMAGING TECHNICAL DIFFERENCES IN CHILDREN | 368 | ||
| PET/MR IMAGING WORKFLOW CONSIDERATIONS | 370 | ||
| MR Imaging Sequence Selection | 370 | ||
| Concern for Gadolinium Administration | 370 | ||
| PET Dose Reduction | 371 | ||
| Other PET Agents | 371 | ||
| Siting and Sedation | 373 | ||
| SUMMARY | 374 | ||
| ACKNOWLEDGMENTS | 374 | ||
| REFERENCES | 374 | ||
| Integration of PET/MR Hybrid Imaging into Radiation Therapy Treatment | 377 | ||
| Key points | 377 | ||
| INTRODUCTION | 377 | ||
| Radiation Therapy: From Simulation to Treatment Delivery | 378 | ||
| Simulation | 378 | ||
| Contouring | 378 | ||
| Treatment planning | 379 | ||
| Treatment delivery | 381 | ||
| Treatment response evaluation | 381 | ||
| From Anatomic Imaging to Functional Imaging | 382 | ||
| PET/MR IMAGING FOR HALLMARKS OF CANCER RADIOBIOLOGY IN RADIATION THERAPY | 383 | ||
| PET/MR Imaging for Metabolism and Proliferation | 384 | ||
| PET/MR Imaging for Angiogenesis and Hypoxia | 392 | ||
| PET/MR Imaging for Better Characterization of Tumor Heterogeneity | 398 | ||
| PET/MR Imaging for Treatment Assessment and Adaptive Radiotherapy | 405 | ||
| PET/MR IMAGING FOR MR IMAGING-BASED RADIATION TREATMENT PLANNING | 414 | ||
| MR Imaging-Based Treatment Planning | 415 | ||
| Differences Between MR Imaging for Radiology and Radiation Oncology | 417 | ||
| Current Implementation and Challenges | 417 | ||
| PET/MR IMAGING FOR RADIATION THERAPY: CHALLENGES AND FUTURE DIRECTIONS | 420 | ||
| Imaging-Specific Uncertainty | 420 | ||
| System-Specific Uncertainty | 421 | ||
| Process-Specific Uncertainty | 421 | ||
| Optimized PET/MR Imaging Workflow | 422 | ||
| SUMMARY | 423 | ||
| REFERENCES | 423 | ||
| Index | 431 |